aluates Reports

$ 0.0

Automative

Global JE Inactivated Vaccine Market Research Report 2025

Published Date: May 2025

Report Code: QYRE-Auto-30J14155

Global JE Inactivated Vaccine Market Research Report 2023

BUY CHAPTERS

Global JE Inactivated Vaccine Market Research Report 2025

Code: QYRE-Auto-30J14155

Report

May 2025

Pages:81

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Bharat Biotech

Biological E Limited

Biken

Seqirus

Liaoning Chengda

Valneva Austria GmbH

JE Inactivated Vaccine Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

JE Inactivated Vaccine Market

The global market for JE Inactivated Vaccine was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Inactivated vaccines are safer

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for JE Inactivated Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding JE Inactivated Vaccine.

The JE Inactivated Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global JE Inactivated Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the JE Inactivated Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of JE Inactivated Vaccine Market Report

Report Metric	Details
Report Name	JE Inactivated Vaccine Market
CAGR	5%
Segment by Type	Hamster Kidney Cells Vero Cells
Segment by Application	Hospital Clinic
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Bharat Biotech, Biological E. Limited, Biken, Seqirus, Liaoning Chengda, Valneva Austria GmbH
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of JE Inactivated Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of JE Inactivated Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the JE Inactivated Vaccine Market report?

Ans: The main players in the JE Inactivated Vaccine Market are Bharat Biotech, Biological E. Limited, Biken, Seqirus, Liaoning Chengda, Valneva Austria GmbH

What are the Application segmentation covered in the JE Inactivated Vaccine Market report?

Ans: The Applications covered in the JE Inactivated Vaccine Market report are Hospital, Clinic

What are the Type segmentation covered in the JE Inactivated Vaccine Market report?

Ans: The Types covered in the JE Inactivated Vaccine Market report are Hamster Kidney Cells, Vero Cells

Recommended Reports

Vaccine Market

Vaccine Components

Specialty Vaccines

1 JE Inactivated Vaccine Market Overview

1.1 Product Definition

1.2 JE Inactivated Vaccine by Type

1.2.1 Global JE Inactivated Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Hamster Kidney Cells

1.2.3 Vero Cells

1.3 JE Inactivated Vaccine by Application

1.3.1 Global JE Inactivated Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Clinic

1.4 Global JE Inactivated Vaccine Market Size Estimates and Forecasts

1.4.1 Global JE Inactivated Vaccine Revenue 2020-2031

1.4.2 Global JE Inactivated Vaccine Sales 2020-2031

1.4.3 Global JE Inactivated Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 JE Inactivated Vaccine Market Competition by Manufacturers

2.1 Global JE Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global JE Inactivated Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global JE Inactivated Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of JE Inactivated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of JE Inactivated Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of JE Inactivated Vaccine, Product Type & Application

2.7 Global Key Manufacturers of JE Inactivated Vaccine, Date of Enter into This Industry

2.8 Global JE Inactivated Vaccine Market Competitive Situation and Trends

2.8.1 Global JE Inactivated Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest JE Inactivated Vaccine Players Market Share by Revenue

2.8.3 Global JE Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global JE Inactivated Vaccine Market Scenario by Region

3.1 Global JE Inactivated Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global JE Inactivated Vaccine Sales by Region: 2020-2031

3.2.1 Global JE Inactivated Vaccine Sales by Region: 2020-2025

3.2.2 Global JE Inactivated Vaccine Sales by Region: 2026-2031

3.3 Global JE Inactivated Vaccine Revenue by Region: 2020-2031

3.3.1 Global JE Inactivated Vaccine Revenue by Region: 2020-2025

3.3.2 Global JE Inactivated Vaccine Revenue by Region: 2026-2031

3.4 North America JE Inactivated Vaccine Market Facts & Figures by Country

3.4.1 North America JE Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America JE Inactivated Vaccine Sales by Country (2020-2031)

3.4.3 North America JE Inactivated Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe JE Inactivated Vaccine Market Facts & Figures by Country

3.5.1 Europe JE Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe JE Inactivated Vaccine Sales by Country (2020-2031)

3.5.3 Europe JE Inactivated Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific JE Inactivated Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific JE Inactivated Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific JE Inactivated Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific JE Inactivated Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America JE Inactivated Vaccine Market Facts & Figures by Country

3.7.1 Latin America JE Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America JE Inactivated Vaccine Sales by Country (2020-2031)

3.7.3 Latin America JE Inactivated Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa JE Inactivated Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa JE Inactivated Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa JE Inactivated Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa JE Inactivated Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global JE Inactivated Vaccine Sales by Type (2020-2031)

4.1.1 Global JE Inactivated Vaccine Sales by Type (2020-2025)

4.1.2 Global JE Inactivated Vaccine Sales by Type (2026-2031)

4.1.3 Global JE Inactivated Vaccine Sales Market Share by Type (2020-2031)

4.2 Global JE Inactivated Vaccine Revenue by Type (2020-2031)

4.2.1 Global JE Inactivated Vaccine Revenue by Type (2020-2025)

4.2.2 Global JE Inactivated Vaccine Revenue by Type (2026-2031)

4.2.3 Global JE Inactivated Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global JE Inactivated Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global JE Inactivated Vaccine Sales by Application (2020-2031)

5.1.1 Global JE Inactivated Vaccine Sales by Application (2020-2025)

5.1.2 Global JE Inactivated Vaccine Sales by Application (2026-2031)

5.1.3 Global JE Inactivated Vaccine Sales Market Share by Application (2020-2031)

5.2 Global JE Inactivated Vaccine Revenue by Application (2020-2031)

5.2.1 Global JE Inactivated Vaccine Revenue by Application (2020-2025)

5.2.2 Global JE Inactivated Vaccine Revenue by Application (2026-2031)

5.2.3 Global JE Inactivated Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global JE Inactivated Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Bharat Biotech

6.1.1 Bharat Biotech Company Information

6.1.2 Bharat Biotech Description and Business Overview

6.1.3 Bharat Biotech JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Bharat Biotech JE Inactivated Vaccine Product Portfolio

6.1.5 Bharat Biotech Recent Developments/Updates

6.2 Biological E. Limited

6.2.1 Biological E. Limited Company Information

6.2.2 Biological E. Limited Description and Business Overview

6.2.3 Biological E. Limited JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Biological E. Limited JE Inactivated Vaccine Product Portfolio

6.2.5 Biological E. Limited Recent Developments/Updates

6.3 Biken

6.3.1 Biken Company Information

6.3.2 Biken Description and Business Overview

6.3.3 Biken JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Biken JE Inactivated Vaccine Product Portfolio

6.3.5 Biken Recent Developments/Updates

6.4 Seqirus

6.4.1 Seqirus Company Information

6.4.2 Seqirus Description and Business Overview

6.4.3 Seqirus JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Seqirus JE Inactivated Vaccine Product Portfolio

6.4.5 Seqirus Recent Developments/Updates

6.5 Liaoning Chengda

6.5.1 Liaoning Chengda Company Information

6.5.2 Liaoning Chengda Description and Business Overview

6.5.3 Liaoning Chengda JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Liaoning Chengda JE Inactivated Vaccine Product Portfolio

6.5.5 Liaoning Chengda Recent Developments/Updates

6.6 Valneva Austria GmbH

6.6.1 Valneva Austria GmbH Company Information

6.6.2 Valneva Austria GmbH Description and Business Overview

6.6.3 Valneva Austria GmbH JE Inactivated Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Valneva Austria GmbH JE Inactivated Vaccine Product Portfolio

6.6.5 Valneva Austria GmbH Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 JE Inactivated Vaccine Industry Chain Analysis

7.2 JE Inactivated Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 JE Inactivated Vaccine Production Mode & Process Analysis

7.4 JE Inactivated Vaccine Sales and Marketing

7.4.1 JE Inactivated Vaccine Sales Channels

7.4.2 JE Inactivated Vaccine Distributors

7.5 JE Inactivated Vaccine Customer Analysis

8 JE Inactivated Vaccine Market Dynamics

8.1 JE Inactivated Vaccine Industry Trends

8.2 JE Inactivated Vaccine Market Drivers

8.3 JE Inactivated Vaccine Market Challenges

8.4 JE Inactivated Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Bharat Biotech

Biological E Limited

Biken

Seqirus

Liaoning Chengda

Valneva Austria GmbH

List of Tables

Table 1. Global JE Inactivated Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global JE Inactivated Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global JE Inactivated Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global JE Inactivated Vaccine Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global JE Inactivated Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global JE Inactivated Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global JE Inactivated Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market JE Inactivated Vaccine Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of JE Inactivated Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of JE Inactivated Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of JE Inactivated Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of JE Inactivated Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global JE Inactivated Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in JE Inactivated Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global JE Inactivated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global JE Inactivated Vaccine Sales by Region (2020-2025) & (K Units)

Table 18. Global JE Inactivated Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global JE Inactivated Vaccine Sales by Region (2026-2031) & (K Units)

Table 20. Global JE Inactivated Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global JE Inactivated Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global JE Inactivated Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global JE Inactivated Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global JE Inactivated Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America JE Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America JE Inactivated Vaccine Sales by Country (2020-2025) & (K Units)

Table 27. North America JE Inactivated Vaccine Sales by Country (2026-2031) & (K Units)

Table 28. North America JE Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America JE Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe JE Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe JE Inactivated Vaccine Sales by Country (2020-2025) & (K Units)

Table 32. Europe JE Inactivated Vaccine Sales by Country (2026-2031) & (K Units)

Table 33. Europe JE Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe JE Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific JE Inactivated Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific JE Inactivated Vaccine Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific JE Inactivated Vaccine Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific JE Inactivated Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific JE Inactivated Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America JE Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America JE Inactivated Vaccine Sales by Country (2020-2025) & (K Units)

Table 42. Latin America JE Inactivated Vaccine Sales by Country (2026-2031) & (K Units)

Table 43. Latin America JE Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America JE Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa JE Inactivated Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa JE Inactivated Vaccine Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa JE Inactivated Vaccine Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa JE Inactivated Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa JE Inactivated Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global JE Inactivated Vaccine Sales (K Units) by Type (2020-2025)

Table 51. Global JE Inactivated Vaccine Sales (K Units) by Type (2026-2031)

Table 52. Global JE Inactivated Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global JE Inactivated Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global JE Inactivated Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global JE Inactivated Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global JE Inactivated Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global JE Inactivated Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global JE Inactivated Vaccine Price (US$/Unit) by Type (2020-2025)

Table 59. Global JE Inactivated Vaccine Price (US$/Unit) by Type (2026-2031)

Table 60. Global JE Inactivated Vaccine Sales (K Units) by Application (2020-2025)

Table 61. Global JE Inactivated Vaccine Sales (K Units) by Application (2026-2031)

Table 62. Global JE Inactivated Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global JE Inactivated Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global JE Inactivated Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global JE Inactivated Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global JE Inactivated Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global JE Inactivated Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global JE Inactivated Vaccine Price (US$/Unit) by Application (2020-2025)

Table 69. Global JE Inactivated Vaccine Price (US$/Unit) by Application (2026-2031)

Table 70. Bharat Biotech Company Information

Table 71. Bharat Biotech Description and Business Overview

Table 72. Bharat Biotech JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Bharat Biotech JE Inactivated Vaccine Product

Table 74. Bharat Biotech Recent Developments/Updates

Table 75. Biological E. Limited Company Information

Table 76. Biological E. Limited Description and Business Overview

Table 77. Biological E. Limited JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Biological E. Limited JE Inactivated Vaccine Product

Table 79. Biological E. Limited Recent Developments/Updates

Table 80. Biken Company Information

Table 81. Biken Description and Business Overview

Table 82. Biken JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Biken JE Inactivated Vaccine Product

Table 84. Biken Recent Developments/Updates

Table 85. Seqirus Company Information

Table 86. Seqirus Description and Business Overview

Table 87. Seqirus JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Seqirus JE Inactivated Vaccine Product

Table 89. Seqirus Recent Developments/Updates

Table 90. Liaoning Chengda Company Information

Table 91. Liaoning Chengda Description and Business Overview

Table 92. Liaoning Chengda JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Liaoning Chengda JE Inactivated Vaccine Product

Table 94. Liaoning Chengda Recent Developments/Updates

Table 95. Valneva Austria GmbH Company Information

Table 96. Valneva Austria GmbH Description and Business Overview

Table 97. Valneva Austria GmbH JE Inactivated Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Valneva Austria GmbH JE Inactivated Vaccine Product

Table 99. Valneva Austria GmbH Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. JE Inactivated Vaccine Distributors List

Table 103. JE Inactivated Vaccine Customers List

Table 104. JE Inactivated Vaccine Market Trends

Table 105. JE Inactivated Vaccine Market Drivers

Table 106. JE Inactivated Vaccine Market Challenges

Table 107. JE Inactivated Vaccine Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of JE Inactivated Vaccine

Figure 2. Global JE Inactivated Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global JE Inactivated Vaccine Market Share by Type: 2024 & 2031

Figure 4. Hamster Kidney Cells Product Picture

Figure 5. Vero Cells Product Picture

Figure 6. Global JE Inactivated Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global JE Inactivated Vaccine Market Share by Application: 2024 & 2031

Figure 8. Hospital

Figure 9. Clinic

Figure 10. Global JE Inactivated Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global JE Inactivated Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global JE Inactivated Vaccine Sales (2020-2031) & (K Units)

Figure 13. Global JE Inactivated Vaccine Average Price (US$/Unit) & (2020-2031)

Figure 14. JE Inactivated Vaccine Report Years Considered

Figure 15. JE Inactivated Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global JE Inactivated Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest JE Inactivated Vaccine Players: Market Share by Revenue in JE Inactivated Vaccine in 2024

Figure 18. JE Inactivated Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global JE Inactivated Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America JE Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America JE Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. United States JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe JE Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe JE Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific JE Inactivated Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific JE Inactivated Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Southeast Asia JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Latin America JE Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 41. Latin America JE Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 42. Mexico JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Brazil JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Argentina JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Middle East and Africa JE Inactivated Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Middle East and Africa JE Inactivated Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Turkey JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. UAE JE Inactivated Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Global Sales Market Share of JE Inactivated Vaccine by Type (2020-2031)

Figure 51. Global Revenue Market Share of JE Inactivated Vaccine by Type (2020-2031)

Figure 52. Global JE Inactivated Vaccine Price (US$/Unit) by Type (2020-2031)

Figure 53. Global Sales Market Share of JE Inactivated Vaccine by Application (2020-2031)

Figure 54. Global Revenue Market Share of JE Inactivated Vaccine by Application (2020-2031)

Figure 55. Global JE Inactivated Vaccine Price (US$/Unit) by Application (2020-2031)

Figure 56. JE Inactivated Vaccine Value Chain

Figure 57. Channels of Distribution (Direct Vs Distribution)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Live Attenuated Japanese Encephalitis Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Poultry Vaccines Market Research Report 2024

mRNA Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Inactivated Influenza Virus Vaccine Market Research Report 2025

COVID 19 Inactivated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Live and Attenuated Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Commercial Fish Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

the End To End Vaccine Supply Chain Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Virus Sampling Tube Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccine Container Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Vaccines for the Elderly Market Research Report 2024

Animal Flu Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Coronavirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Gram Negative lnfections Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inactivated Influenza Vaccine Market

Japanese Encephalitis Virus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Novel Coronavirus Inactivated Vaccine Market Research Report 2025

Vaccine Refrigerant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Electric Vaccine Vehicle Market Research Report 2025

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions